Is ITCI Stock A Buy or Sell?
In this article we will check out the progression of hedge fund sentiment towards Intra-Cellular Therapies Inc (NASDAQ:ITCI) and determine whether it is a good investment right now. We at Insider Monkey...
Intra-Cellular Therapies Inc. (ITCI)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 1,496,006 | $50,759 | +5% | 0.01% |
| 2. | Samlyn Capital Robert Pohly | 1,369,606 | $46,471 | -18% | 0.64% |
| 3. | Suvretta Capital Management Aaron Cowen | 1,038,770 | $35,245 | +15% | 0.52% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 800,000 | $27,144 | +5% | 0.05% |
| 5. | Millennium Management Israel Englander | 798,052 | $27,078 | -50% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.60 | 49,500 | Director | 4,743,770 | 2020-09-14 | Filing | |
| $28.08 | 21,000 | Director | 4,694,270 | 2020-09-11 | Filing | |
| $11.00 | 6,240 | Large Shareholder, Director | 4,673,270 | 2019-09-10 | Filing | |
| $10.58 | 320,095 | Large Shareholder, Director | 4,667,030 | 2019-09-10 | Filing | |
| $9.59 | 155,116 | Large Shareholder, Director | 4,346,935 | 2019-09-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.27 | 18,289 | Director | 48,980 | 2021-06-14 | Filing | |
| $40.12 | 38,843 | Director | 95,000 | 2021-05-28 | Filing | |
| $40.01 | 8,482 | Director | 133,843 | 2021-05-27 | Filing | |
| $40.47 | 26,575 | Director | 142,325 | 2021-05-24 | Filing | |
| $40.00 | 1,100 | Director | 168,900 | 2021-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 67,208 | $2,280,367 | 0% | |
| 2. | 20,316 | $689,322 | 0% | |
| 3. | 12,137,522 | $411,826 | 0.04% | |
| 4. | 6,721,693 | $228,067 | 0% | |
| 5. | 6,525,323 | $221,405 | 1.01% |
News See All
Did Hedge Funds Make The Right Call On Intra-Cellular Therapies Inc (ITCI)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F...
Do Hedge Funds Love Intra-Cellular Therapies Inc (ITCI)?
In this article you are going to find out whether hedge funds think Intra-Cellular Therapies Inc (NASDAQ:ITCI) is a good investment right now. We like to check what the smart money thinks first before...
Intra-Cellular Therapies Inc (ITCI): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index...
5 Stocks Financial Advisors Are Looking To Buy This Week
All three main indexes appreciated last week as investors maintained a bullish sentiment following positive news in the last several weeks. The Dow Jones Industrial Average inched higher by 0.33%, while...
Did Hedge Funds Drop The Ball On Intra-Cellular Therapies Inc (ITCI) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been Less Bullish On Intra-Cellular Therapies Inc (ITCI)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and these...
Here is What Hedge Funds Think About Intra-Cellular Therapies Inc (ITCI)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% differential (up...
Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More
Kerrisdale Capital, the US hedge fund that made a public enemy of Neil Woodford after shorting two of his prominent holdings, is no longer making bets against companies backed by the embattled UK stock...
Hedge Fund and Insider Trading News: Neil Woodford, Falcon Edge Capital, Alma Capital, Intra-Cellular Therapies Inc (ITCI), Ormat Technologies Inc (ORA), and More
LONDON (Reuters) - The suspension of Neil Woodford’s flagship fund has put the focus on a little known firm tasked with ensuring his investors were being looked after properly. While Woodford, one of...
Billionaire Hedge Funds
